← Leaderboards

William E Klunk

University Of Pittsburgh At Pittsburgh

Google Scholar ↗PubMed ↗ORCID ↗

$26,129,826

Attributed

$41,440,109

Total exposure

19

Grants

16

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.7M · FY2005–20

$10M$7.5M$5M$2.5M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

Funding mix

By agency

NIH$59,008,299 · 20

By mechanism

P01$24,427,774 · 12

U01$22,686,668 · 2

R37$4,271,551 · 1

RF1$3,484,764 · 1

P50$1,869,976 · 2

R01$1,779,136 · 1

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Milos D Ikonomovic$11,868,106
Oscar L. Lopez$26,660,804
Chester A Mathis$13,083,881
Ronald L Hamilton$2,372,992
Karen A Norris$27,323,771

Others in their field

Top investigators on “Alzheimer&Apos”

Jose A Luchsinger · Columbia University Health Sciences$56,595,040
Eric M Reiman · Banner Health$48,982,487
Yadong Huang · J. David Gladstone Institutes$40,311,515
Lindsay A. Farrer · Boston University Medical Campus$34,189,802
David M Holtzman · Washington University$28,985,806
Michael W Weiner · Northern California Institute Res &Educ$28,197,224

Research focus

Alzheimer&AposS DiseasePositron-Emission TomographyBrainDepositionImageAmyloidCognitiveFunctional DisorderAmyloid Beta-ProteinIn VivoUniversitiesAgingAmyloid ImagingDementiaCognitionAutopsySymptomsAmyloid DepositionImpaired CognitionPathologyNeuroimagingProgramsCohort

Grant awards (91)

Tau Imaging with [F-18]AV-1451: Considerations for Performance across the Spectrum of Disease Severity$290,301

P01 · FY2020 · AG · contact PI

Administrative Core$173,510

P01 · FY2020 · AG · contact PI

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease$4,277,120

U01 · FY2019 · AG

Imaging Pathophysiology in Aging and Neurodegeneration$2,188,440

P01 · FY2019 · AG · contact PI

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease$586,856

U01 · FY2019 · AG

Tau Imaging with [F-18]AV-1451: Considerations for Performance across the Spectrum of Disease Severity$345,259

P01 · FY2019 · AG · contact PI

Administrative Core$176,566

P01 · FY2019 · AG · contact PI

Imaging Pathophysiology in Aging and NeurodegenerationProject-5: Image Quantitation Enhancement for Amyloid and Tau PET$156,679

P01 · FY2019 · AG · contact PI

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease$3,742,475

U01 · FY2018 · AG

Imaging Pathophysiology in Aging and Neurodegeneration$1,995,282

P01 · FY2018 · AG · contact PI

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease$386,628

U01 · FY2018 · AG

Tau Imaging with [F-18]AV-1451: Considerations for Performance across the Spectrum of Disease Severity$331,861

P01 · FY2018 · AG · contact PI

Administrative Core$158,153

P01 · FY2018 · AG · contact PI

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease$129,573

U01 · FY2018 · AG

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease$69,940

U01 · FY2018 · AG

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease$3,623,562

U01 · FY2017 · AG

Imaging Pathophysiology in Aging and Neurodegeneration$2,020,576

P01 · FY2017 · AG · contact PI

Tau Imaging with [F-18]AV-1451: Considerations for Performance across the Spectrum of Disease Severity$323,975

P01 · FY2017 · AG · contact PI

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease$163,334

U01 · FY2017 · AG

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease$158,939

U01 · FY2017 · AG

Administrative Core$143,654

P01 · FY2017 · AG · contact PI

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease$3,556,865

U01 · FY2016 · AG

Imaging Pathophysiology in Aging and Neurodegeneration$1,998,101

P01 · FY2016 · AG · contact PI

Amyloid Pathology and Cognition in Normal Elderly$782,946

RF1 · FY2016 · AG · contact PI

Tau Imaging with [F-18]AV-1451: Considerations for Performance across the Spectrum of Disease Severity$317,203

P01 · FY2016 · AG · contact PI

Administrative Core$158,152

P01 · FY2016 · AG · contact PI

Neurodegeneration in Aging Down Syndrome (NiAD): A Longitudinal Study of Cognition and Biomarkers of Alzheimer's Disease$3,656,559

U01 · FY2015 · AG

Amyloid Pathology and Cognition in Normal Elderly$2,701,818

RF1 · FY2014 · AG · contact PI

IN VIVO PIB PET AMYLOID IMAGING: NORMALS, MCI & DEMENTIA$1,146,355

P01 · FY2014 · AG · contact PI

Quantitative Neuropathological Correlates of In Vivo PiB Retention$286,635

P01 · FY2014 · AG · contact PI

AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY$227,443

R37 · FY2014 · AG · contact PI

NATURAL HISTORY OF AMYLOID DEPOSITION FAMILIAL AD$182,280

P50 · FY2014 · AG · contact PI

Modulators of Cognitive Transifion from MCI to AD$175,638

P01 · FY2014 · AG · contact PI

Administrative Core$126,259

P01 · FY2014 · AG · contact PI

IN VIVO PIB PET AMYLOID IMAGING: NORMALS, MCI & DEMENTIA$1,295,247

P01 · FY2013 · AG · contact PI

AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY$441,934

R37 · FY2013 · AG · contact PI

Quantitative Neuropathological Correlates of In Vivo PiB Retention$274,558

P01 · FY2013 · AG · contact PI

Modulators of Cognitive Transifion from MCI to AD$267,813

P01 · FY2013 · AG · contact PI

NATURAL HISTORY OF AMYLOID DEPOSITION FAMILIAL AD$170,365

P50 · FY2013 · AG · contact PI

Administrative Core$113,777

P01 · FY2013 · AG · contact PI

IN VIVO PIB PET AMYLOID IMAGING: NORMALS, MCI & DEMENTIA$1,420,069

P01 · FY2012 · AG · contact PI

AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY$480,423

R37 · FY2012 · AG · contact PI

Modulators of Cognitive Transifion from MCI to AD$337,923

P01 · FY2012 · AG · contact PI

Quantitative Neuropathological Correlates of In Vivo PiB Retention$287,620

P01 · FY2012 · AG · contact PI

NATURAL HISTORY OF AMYLOID DEPOSITION FAMILIAL AD$182,113

P50 · FY2012 · AG · contact PI

Administrative Core$126,424

P01 · FY2012 · AG · contact PI

IN VIVO PIB PET AMYLOID IMAGING: NORMALS, MCI & DEMENTIA$1,482,584

P01 · FY2011 · AG · contact PI

AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY$481,954

R37 · FY2011 · AG · contact PI

Modulators of Cognitive Transifion from MCI to AD$346,486

P01 · FY2011 · AG · contact PI

Quantitative Neuropathological Correlates of In Vivo PiB Retention$292,634

P01 · FY2011 · AG · contact PI

NATURAL HISTORY OF AMYLOID DEPOSITION FAMILIAL AD$199,286

P50 · FY2011 · AG · contact PI

Administrative Core$126,512

P01 · FY2011 · AG · contact PI

IN VIVO PIB PET AMYLOID IMAGING: NORMALS, MCI & DEMENTIA$1,538,583

P01 · FY2010 · AG · contact PI

Amyloid-Lowering Small Molecule AB-Binding Agents in AD$504,093

U01 · FY2010 · AG · contact PI

AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY$473,345

R37 · FY2010 · AG · contact PI

Modulators of Cognitive Transifion from MCI to AD$301,836

P01 · FY2010 · AG · contact PI

NATURAL HISTORY OF AMYLOID DEPOSITION FAMILIAL AD$171,025

P50 · FY2010 · AG · contact PI

Administrative Core$129,363

P01 · FY2010 · AG · contact PI

In VivoPIB PET Amyloid Imaging: Normals, MCI & Dementia$1,151,713

P01 · FY2009 · AG · contact PI

Amyloid-Lowering Small Molecule AB-Binding Agents in AD$466,821

U01 · FY2009 · AG · contact PI

AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY$362,933

R37 · FY2009 · AG · contact PI

CROSS-SECTIONAL ASSESSMENT OF IN VIVO AMYLOID IN MCI AND AD$360,047

P01 · FY2009 · AG · contact PI

NATURAL HISTORY OF AMYLOID DEPOSITION IN FAMILIAL ALZHEIMERS DISEASE$221,371

P50 · FY2009 · AG · contact PI

AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY$5,000

R37 · FY2009 · AG · contact PI

In VivoPIB PET Amyloid Imaging: Normals, MCI & Dementia$1,031,916

P01 · FY2008 · AG · contact PI

Amyloid-Lowering Small Molecule AB-Binding Agents in AD$454,087

U01 · FY2008 · AG · contact PI

AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY$449,361

R37 · FY2008 · AG · contact PI

CROSS-SECTIONAL ASSESSMENT OF IN VIVO AMYLOID IN MCI AND AD$259,127

P01 · FY2008 · AG · contact PI

NATURAL HISTORY OF AMYLOID DEPOSITION IN FAMILIAL ALZHEIMERS DISEASE$215,088

P50 · FY2008 · AG · contact PI

In VivoPIB PET Amyloid Imaging: Normals, MCI & Dementia$142,645

P01 · FY2008 · AG · contact PI

AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY$459,409

R37 · FY2007 · AG · contact PI

Amyloid-Lowering Small Molecule AB-Binding Agents in AD$450,738

U01 · FY2007 · AG · contact PI

CROSS-SECTIONAL ASSESSMENT OF IN VIVO AMYLOID IN MCI AND AD$298,271

P01 · FY2007 · AG · contact PI

NATURAL HISTORY OF AMYLOID DEPOSITION IN FAMILIAL ALZHEIMERS DISEASE$214,077

P50 · FY2007 · AG · contact PI

AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY$459,594

R37 · FY2006 · AG · contact PI

Amyloid-Lowering Small Molecule AB-Binding Agents in AD$459,078

U01 · FY2006 · AG · contact PI

CROSS-SECTIONAL ASSESSMENT OF IN VIVO AMYLOID IN MCI AND AD$172,602

P01 · FY2006 · AG · contact PI

NATURAL HISTORY OF AMYLOID DEPOSITION IN FAMILIAL AD$128,746

P50 · FY2006 · AG · contact PI

AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY$430,155

R37 · FY2005 · AG

PET TRACERS TO MONITOR VACCINE AND IMMUNE THERAPY FOR AD$353,050

R01 · FY2005 · AG

NATURAL HISTORY OF AMYLOID DEPOSITION IN FAMILIAL AD$185,625

P50 · FY2005 · AG

CROSS-SECTIONAL ASSESSMENT OF IN VIVO AMYLOID IN MCI AND AD$157,425

P01 · FY2005 · AG

PET IMAGING PROBES FOR AMYLOID IN ALZHEIMERS AND AGING$97,686

K02 · FY2005 · AG

PET TRACERS TO MONITOR VACCINE AND IMMUNE THERAPY FOR AD$353,050

R01 · FY2004 · AG

PET IMAGING PROBES FOR AMYLOID IN ALZHEIMERS AND AGING$97,686

K02 · FY2004 · AG

PET TRACERS TO MONITOR VACCINE AND IMMUNE THERAPY FOR AD$353,050

R01 · FY2003 · AG

PET IMAGING PROBES FOR AMYLOID IN ALZHEIMERS AND AGING$97,686

K02 · FY2003 · AG

PET TRACERS TO MONITOR VACCINE AND IMMUNE THERAPY FOR AD$353,050

R01 · FY2002 · AG

PET IMAGING PROBES FOR AMYLOID IN ALZHEIMERS AND AGING$97,686

K02 · FY2002 · AG

PET TRACERS TO MONITOR VACCINE AND IMMUNE THERAPY FOR AD$366,936

R01 · FY2001 · AG

PET IMAGING PROBES FOR AMYLOID IN ALZHEIMERS AND AGING$97,686

K02 · FY2001 · AG